Skip to content
Back to announcement

20251031_SDPC_Laporan Informasi dan Fakta Material_31981046.pdf

Other Text extracted SDPC

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 4

Page 1
Go To English Page

 Nomor Surat                           1000/MPI/DIR/X/2025

 Nama Perusahaan                       Millennium Pharmacon International Tbk

 Kode Emiten                           SDPC

 Lampiran                              1
                                       Pemberhentian Kerjasama Distribusi dengan PT Puspa Pharma
 Perihal


Dengan ini kami untuk dan atas nama perusahaan menyampaikan Laporan Informasi atau Fakta Material sebagai
berikut:

 Nama Emiten atau Perusahaan Publik            Millennium Pharmacon International Tbk

 Bidang Usaha                                  Perdagangan dan Jasa



 Telepon                                       021-270 85961; 270 85964

 Faksimili                                     021-270 85958

 Alamat Surat Elektronik (email)               investor.relation@mpi-pharmaniaga.co.id


 Tanggal Kejadian                              31 Oktober 2025
 Jenis Informasi atau Fakta Material           Pemberhentian Kerjasama Distribusi dengan PT Puspa
                                               Pharma


 Uraian Informasi atau Fakta Material          PT Millennium Pharmacon International Tbk dan PT Puspa
                                               Pharma telah sepakat untuk mengakhiri kerjasama distribusi
                                               secara resmi.

 Dampak kejadian, informasi atau fakta         Tidak terdapat dampak signifikan terhadap operasional dan
 material tersebut terhadap kegiatan           kelangsungan usaha Perseroan atas pemberhentian
 operasional, hukum, kondisi keuangan,         kerjasama distribusi ini.
 atau kelangsungan usaha Emiten atau
 Perusahaan Publik



 Demikian untuk diketahui.


 Hormat Kami,
 Millennium Pharmacon International Tbk




 Mohamad Fazly bin Hassan

 Direktur




 Millennium Pharmacon International Tbk
 Crown Bungur Arteri Lantai 2-4, Jl. Sultan Iskandar Muda No.18, Kel. Kebayoran
 Telepon : 021-270 85961; 270 85964, Fax : 021-270 85958, www.mpi-indonesia.co.id



 Nama Pengirim                         Mohamad Fazly bin Hassan
Page 2
Jabatan                           Direktur
Tanggal dan Waktu                 31-10-2025 09:48

Lampiran                          1. KI Pemberhentian Kerjasama_PT Puspa Pharma.pdf


  Dokumen ini merupakan dokumen resmi Millennium Pharmacon International Tbk yang tidak memerlukan tanda
 tangan karena dihasilkan secara elektronik oleh sistem pelaporan elektronik. Millennium Pharmacon International
                 Tbk bertanggung jawab penuh atas informasi yang tertera didalam dokumen ini.
Page 3
Go To Indonesian Page

 Letter / Announcement No.            1000/MPI/DIR/X/2025

 Issuer Name                          Millennium Pharmacon International Tbk

 Issuer Code                          SDPC

 Attachment                           1

 Subject                              Termination of Distribution Cooperation with PT Puspa Pharma


The company hereby announce the Material Information or Facts Report as follows

 Name of Issuer or Public Company               Millennium Pharmacon International Tbk

 Business Activities                            Perdagangan dan Jasa


 Telephone                                      021-270 85961; 270 85964

 Faximile                                       021-270 85958

 Email Address                                  investor.relation@mpi-pharmaniaga.co.id


 Date of Event                                  31 October 2025

                                                Termination of Distribution Cooperation with PT Puspa Pharma
 Type of Material Information or Facts

 Description of Material Information or         PT Millennium Pharmacon International Tbk and PT Puspa
 Facts                                          Pharma have agreed to officially end the distribution
                                                cooperation.

 Impact of event, material information or       There is no significant impact on the company's operation and
 facts towards Issuers or Public                business continuity with the termination of this distribution
 Company’s operational activities, legal,       cooperation.
 financial condition, or going concern




Thus to be informed accordingly.


Respectfully,
Millennium Pharmacon International Tbk




Mohamad Fazly bin Hassan

Direktur




Millennium Pharmacon International Tbk
Crown Bungur Arteri Lantai 2-4, Jl. Sultan Iskandar Muda No.18, Kel. Kebayoran
Phone : 021-270 85961; 270 85964, Fax : 021-270 85958, www.mpi-indonesia.co.id



Sender Name                          Mohamad Fazly bin Hassan

Function                             Direktur

Date and Time                        31-10-2025 09:48
Page 4
Attachment                        1. KI Pemberhentian Kerjasama_PT Puspa Pharma.pdf


 This is an official document of Millennium Pharmacon International Tbk that does not require a signature as it was
    generated electronically by the electronic reporting system. Millennium Pharmacon International Tbk is fully
                           responsible for the information contained within this document.

File

File Open PDF
Source IDX
Size0.01 MB
Published31 Oct 2025
Pages4
Characters5,085
Text sourceEmbedded text layer
OCR confidence—

Names mentioned 6 people and organisations named in the text · linked when the evidence is strong

linked org Millennium Pharmacon International Tbk · Nama Perusahaan p.1 ×28
unresolved org PT Puspa Pharma p.1 ×4
unresolved org PT Puspa Pharma Uraian Informasi p.1
unresolved person Mohamad Fazly bin Hassan · Nama Pengirim p.1 ×3
unresolved org PT Puspa p.3
unresolved person Function · Direktur p.3

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

No extraction attempted yet.

↑↓ select ↵ open ⇧↵ see every result